| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/07/2023 | Alkermes plc. | ALKS | Payment of Exercise | Ordinary Shares | 1.4k | $29.88 | $42.7k | | 07/07/2023 |
| 07/07/2023 | Alkermes plc. | ALKS | Exercise | Restricted Stock Unit Award | 6k | $0.00 | $0 | | 07/07/2023 |
| 06/30/2023 | Lyra Therapeutics, Inc. | LYRA | Grant | Stock Option | 20k | $4.11 | $82.2k | | 06/30/2023 |
| 06/29/2023 | Alkermes plc. | ALKS | Grant | Non Qualified Stock Option (Right to Buy) | 12.7k | $31.33 | $398.9k | | 06/29/2023 |
| 06/29/2023 | Alkermes plc. | ALKS | Grant | Restricted Stock Unit Award | 6k | $0.00 | $0 | | 06/29/2023 |
| 06/26/2023 | Axonics, Inc. | AXNX | Grant | Common Stock | 3k | $0.00 | $0 | | 06/26/2023 |
| 08/18/2022 | Axonics, Inc. | AXNX | Grant | Common Stock | 2.1k | $0.00 | $0 | | 08/18/2022 |
| 07/07/2022 | Alkermes plc. | ALKS | Grant | Restricted Stock Unit Award | 6k | $0.00 | $0 | | 07/07/2022 |
| 07/07/2022 | Alkermes plc. | ALKS | Grant | Non Qualified Stock Option (Right to Buy) | 11.6k | $31.48 | $363.7k | | 07/07/2022 |
| 06/16/2022 | Lyra Therapeutics, Inc. | LYRA | Grant | Stock Option | 7.2k | $5.09 | $36.9k | | 06/16/2022 |
| 06/14/2022 | Alkermes plc. | ALKS | Payment of Exercise | Ordinary Shares | 695 | $27.19 | $18.9k | | 06/14/2022 |
| 06/14/2022 | Alkermes plc. | ALKS | Exercise | Restricted Stock Unit Award | 7.6k | $0.00 | $0 | | 06/14/2022 |
| 03/04/2022 | Alkermes plc. | ALKS | Purchase | Ordinary Shares | 427 | $23.43 | $10k | | 03/04/2022 |
| 12/02/2021 | Alkermes plc. | ALKS | Payment of Exercise | Ordinary Shares | 1.3k | $22.11 | $29.6k | | 12/02/2021 |
| 12/02/2021 | Alkermes plc. | ALKS | Exercise | Restricted Stock Unit Award | 5.6k | $0.00 | $0 | | 12/02/2021 |
| 10/24/2021 | Future Health ESG Corp. | | Disposition | Common stock, par value $0.0001 per share | 1.7k | $0.00 | $0 | | 10/24/2021 |
| 10/24/2021 | Future Health ESG Corp. | | Disposition | Common stock, par value $0.0001 per share | 1.7k | $0.00 | $0 | See footnote | 10/24/2021 |
| 10/22/2021 | Axonics, Inc. | AXNX | Grant | Common Stock | 2.3k | $0.00 | $0 | | 10/22/2021 |
| 09/14/2021 | Future Health ESG Corp. | | Purchase | Warrant | 27.4k | $1.00 | $27.4k | See Footnote | 09/14/2021 |
| 06/14/2021 | Alkermes plc. | ALKS | Grant | Non Qualified Stock Option (Right to Buy) | 15.7k | $24.72 | $387.5k | | 06/14/2021 |
| 06/14/2021 | Alkermes plc. | ALKS | Grant | Restricted Stock Unit Award | 7.6k | $0.00 | $0 | | 06/14/2021 |
| 05/26/2021 | Lyra Therapeutics, Inc. | LYRA | Grant | Stock Option | 7.2k | $7.24 | $52.5k | | 05/26/2021 |
| 05/20/2021 | Alkermes plc. | ALKS | Payment of Exercise | Ordinary Shares | 1.4k | $21.92 | $30.8k | | 05/20/2021 |
| 05/20/2021 | Alkermes plc. | ALKS | Exercise | Restricted Stock Unit Award | 6.1k | $0.00 | $0 | | 05/20/2021 |
| 12/16/2020 | Lyra Therapeutics, Inc. | LYRA | Purchase | Common Stock | 1k | $9.72 | $10k | | 12/16/2020 |
| 12/02/2020 | Alkermes plc. | ALKS | Grant | Non Qualified Stock Option (Right to Buy) | 11.5k | $18.82 | $216.6k | | 12/02/2020 |
| 12/02/2020 | Alkermes plc. | ALKS | Grant | Restricted Stock Unit Award | 5.6k | $0.00 | $0 | | 12/02/2020 |
| 10/27/2020 | Lyra Therapeutics, Inc. | LYRA | Grant | Stock Option | 14.5k | $11.76 | $170.5k | | 10/27/2020 |
| 08/24/2020 | Axonics, Inc. | AXNX | Grant | Common Stock | 3.5k | $0.00 | $0 | | 08/24/2020 |
| 05/20/2020 | Alkermes plc. | ALKS | Grant | Non Qualified Stock Option (Right to Buy) | 12.8k | $16.85 | $216.1k | | 05/20/2020 |
| 05/20/2020 | Alkermes plc. | ALKS | Grant | Restricted Stock Unit Award | 6.1k | $0.00 | $0 | | 05/20/2020 |
| 08/22/2019 | Axonics, Inc. | AXNX | Grant | Common Stock | 2.1k | $0.00 | $0 | | 08/22/2019 |
| 08/22/2019 | Axonics, Inc. | AXNX | Grant | Stock Option (Right to Buy) | 4.2k | $34.10 | $142.1k | | 08/22/2019 |
| 06/27/2019 | Axonics, Inc. | AXNX | Purchase | Common Stock | 2k | $37.12 | $74.2k | | 06/27/2019 |
| 05/22/2019 | Alkermes plc. | ALKS | Grant | Non Qualified Stock Option (Right to Buy) | 22.4k | $25.04 | $560.9k | | 05/22/2019 |
|